McAdam LLC’s National Health Investors NHI Stock Holding History

McAdam LLC’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11	Closed	-$1K	–	751
2018 Q1	$1K	Buy	+11	New	+$752	﹤0.01%	676

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

McAdam LLC's NHI Position: Q2 2018 in Review

McAdam LLC sold out of National Health Investors (NHI) in Q2 2018, closing a stake of 11 shares — an estimated $1K sold.

McAdam LLC first reported a position in NHI in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 239 funds tracked by Wall St. Rank hold NHI as of Q2 2018.

McAdam LLC reported no remaining National Health Investors position as of Q2 2018 after selling out during the quarter.
McAdam LLC sold 11 National Health Investors shares in Q2 2018, an estimated $1K.
McAdam LLC first reported a position in National Health Investors in Q1 2018 and held it in 1 quarter.
McAdam LLC's National Health Investors position peaked at $1K in Q1 2018.
239 funds tracked by Wall St. Rank held National Health Investors as of Q2 2018.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.